|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0003316,
umls-concept:C0003320,
umls-concept:C0020792,
umls-concept:C0039195,
umls-concept:C0205263,
umls-concept:C0205369,
umls-concept:C0301872,
umls-concept:C0536940,
umls-concept:C1413787,
umls-concept:C1704858,
umls-concept:C2825965
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2004-2-11
|
|
pubmed:abstractText |
For the development of peptide-based, cancer-specific immunotherapy, the identification of CTL epitopes from additional tumor antigens is very important. NY-ESO-1, a cancer-testis antigen, is considered to be a promising target of tumor-specific immunotherapy. Because HLA-A24-expressing individuals cover >60% in the population of Japan, we aim at identifying NY-ESO-1-encoded peptide presented by HLA-A24.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Neoplasm,
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/CTAG1B protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Cytokines,
http://linkedlifedata.com/resource/pubmed/chemical/DNA, Complementary,
http://linkedlifedata.com/resource/pubmed/chemical/Epitopes,
http://linkedlifedata.com/resource/pubmed/chemical/HLA-A Antigens,
http://linkedlifedata.com/resource/pubmed/chemical/HLA-A24 Antigen,
http://linkedlifedata.com/resource/pubmed/chemical/Membrane Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Peptides
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
1078-0432
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
10
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
890-6
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:14871964-Antigens,
pubmed-meshheading:14871964-Antigens, Neoplasm,
pubmed-meshheading:14871964-Antineoplastic Agents,
pubmed-meshheading:14871964-CD8-Positive T-Lymphocytes,
pubmed-meshheading:14871964-Cell Line,
pubmed-meshheading:14871964-Cell Line, Tumor,
pubmed-meshheading:14871964-Cytokines,
pubmed-meshheading:14871964-DNA, Complementary,
pubmed-meshheading:14871964-Dendritic Cells,
pubmed-meshheading:14871964-Epitopes,
pubmed-meshheading:14871964-HLA-A Antigens,
pubmed-meshheading:14871964-HLA-A24 Antigen,
pubmed-meshheading:14871964-Humans,
pubmed-meshheading:14871964-Immunotherapy,
pubmed-meshheading:14871964-Leukocytes, Mononuclear,
pubmed-meshheading:14871964-Membrane Proteins,
pubmed-meshheading:14871964-Neoplasms,
pubmed-meshheading:14871964-Peptides,
pubmed-meshheading:14871964-Protein Binding,
pubmed-meshheading:14871964-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:14871964-T-Lymphocytes, Cytotoxic
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Identification of HLA-A24-restricted CTL epitope from cancer-testis antigen, NY-ESO-1, and induction of a specific antitumor immune response.
|
|
pubmed:affiliation |
Division of Molecular and Surgical Oncology, Department of Molecular and Cellular Biology, Medical Institute of Bioregulation, Kyushu University, 4546 Tsurumihara, 874-0838 Beppu, Japan.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
